DS

Devavrat Sanjeev Kulkarni

Active Director Director DIN 09375795
DIN 09375795 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Devavrat Sanjeev Kulkarni

Data last updated:

Devavrat Sanjeev Kulkarni is a Director at Anant Pharmasol Private Limited (since 2021). The company operates in Chemicals.

DIN 09375795
Primary Designation Director
Industry Chemicals
First Appointment 26 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Anant Pharmasol Private Limited U24290PN2021PTC205584
Director26 Oct 20212021Active

Board colleagues of Devavrat Sanjeev Kulkarni

NameDINCompanyDesignation
Sanjeev Anant Kulkarni09375794Anant Pharmasol Private LimitedDirector

Directorship timeline

Open interactive timeline →
Anant Pharmasol Private Limited
Premium access

Shareholding and investment profile for Devavrat Sanjeev Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devavrat Sanjeev Kulkarni

Devavrat Sanjeev Kulkarni currently holds 1 directorship: Anant Pharmasol Private Limited (Director, since 26 Oct 2021).

Devavrat Sanjeev Kulkarni was first appointed on 26 Oct 2021 as Director at Anant Pharmasol Private Limited.

The current boards of Devavrat Sanjeev Kulkarni's companies include Sanjeev Anant Kulkarni (Anant Pharmasol Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available